EP2061448
SUSTAINED RELEASE FORMULATION OF NALTREXONE
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
31.5.2007EP published:
17.7.2019EP application number:
07795652.2
EPO information:
European Patent Register
Max expiry date:
30.5.2027
Title:
SUSTAINED RELEASE FORMULATION OF NALTREXONE
Timeline
Today
31.5.2007EP application
17.7.2019EP Publication
Owner
Name:
Nalpropion Pharmaceuticals LLCAddress:
10 North Place Park, Suite 201, Morristown, NJ 07960, US
Inventor
Name:
MCKINNEY, Anthony A.Address:
San Diego, California, US
Name:
TOLLEFSON, Gary D.Address:
Indianapolis, Indiana, US
Name:
SOLTERO, RichardAddress:
Holly Springs, North Carolina, US
Name:
DUNZO, Thea EliseAddress:
Durham, North Carolina, US
Priority
Number:
811251 PDate:
5.6.2006Country:
US
Number:
841114 PDate:
29.8.2006Country:
US
Classification
Categories:
A61K 31/135, A61K 31/137, A61K 31/485, A61K 9/20